about
Triglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseOlive oil and postprandial hyperlipidemia: implications for atherosclerosis and metabolic syndrome.microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis.Association between metabolic syndrome and pelvic organ prolapse severity.Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic SteatosisApoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia.Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients.Association of the variants and haplotypes in the DOCK7, PCSK9 and GALNT2 genes and the risk of hyperlipidaemia.Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism.Lomitapide for the treatment of hypertriglyceridemia.Cholesterol Levels of Six Fractionated Serum Lipoproteins and its Relevance to Coronary Heart Disease Risk Scores.More data needed on curcuminoids in hypertriglyceridaemia.Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.Challenges in the treatment of hypertriglyceridemia: glass half empty or half full?Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.Effects of aging on serum levels of lipid molecular species as determined by lipidomics analysis in Japanese men and women.
P2860
Q26745946-2E676C39-69FD-4CA9-8A80-A0EC3BD60BBCQ30240705-5D919D8C-F625-4831-9611-57EA48DFC4C4Q35116623-F25DCFF9-B5A2-4015-91E9-2941977B7983Q35212239-829EDA39-3EF7-4835-95F3-8BCC43A22F7FQ35783538-3D64018B-6847-4302-A003-7B51599DC781Q35923466-79382EE5-5CCC-446A-8E38-39638C5DF823Q35995921-2599F8D0-82CE-4971-B179-D15D5376040DQ36255629-1261F61F-5F74-4543-BD90-EC05BB1E0193Q36504294-AE5C27AF-6144-4075-AD39-E2C7EE95B463Q38839105-CB16288E-58C6-4D8A-A7EC-B4A24F20B6C5Q38992251-1B7F2044-2D1C-458D-B529-B2317D25E833Q39063207-3B58FB5E-A4D9-40F1-84A5-79671CA74726Q45200080-BF1D665A-4A81-40C6-958A-2004F1C1B633Q50099270-9CF28176-0E8B-4245-ABEB-0F2B0FC709EDQ51301866-2787AFBF-7842-460C-AC51-89052A970D80Q55176268-2294441B-4A9C-480A-85F1-14CF9BC8B277Q55279247-883A3369-4BB1-423A-9D5D-8AE8B7CB488D
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Demystifying the management of hypertriglyceridaemia.
@en
type
label
Demystifying the management of hypertriglyceridaemia.
@en
prefLabel
Demystifying the management of hypertriglyceridaemia.
@en
P2093
P2860
P50
P1476
Demystifying the management of hypertriglyceridaemia
@en
P2093
Dick C Chan
Esther M M Ooi
Gerald F Watts
P2860
P304
P356
10.1038/NRCARDIO.2013.140
P407
P577
2013-09-24T00:00:00Z